Log in to save to my catalogue

SPTLC2 variants are associated with early‐onset ALS and FTD due to aberrant sphingolipid synthesis

SPTLC2 variants are associated with early‐onset ALS and FTD due to aberrant sphingolipid synthesis

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_a933b528a8fe470791e3994a6a0b880c

SPTLC2 variants are associated with early‐onset ALS and FTD due to aberrant sphingolipid synthesis

About this item

Full title

SPTLC2 variants are associated with early‐onset ALS and FTD due to aberrant sphingolipid synthesis

Publisher

United States: John Wiley & Sons, Inc

Journal title

Annals of Clinical and Translational Neurology, 2024-04, Vol.11 (4), p.946-957

Language

English

Formats

Publication information

Publisher

United States: John Wiley & Sons, Inc

More information

Scope and Contents

Contents

Objective
Amyotrophic lateral sclerosis (ALS) is a devastating, incurable neurodegenerative disease. A subset of ALS patients manifests with early‐onset and complex clinical phenotypes. We aimed to elucidate the genetic basis of these cases to enhance our understanding of disease etiology and facilitate the development of targeted therapies.
...

Alternative Titles

Full title

SPTLC2 variants are associated with early‐onset ALS and FTD due to aberrant sphingolipid synthesis

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_a933b528a8fe470791e3994a6a0b880c

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_a933b528a8fe470791e3994a6a0b880c

Other Identifiers

ISSN

2328-9503

E-ISSN

2328-9503

DOI

10.1002/acn3.52013

How to access this item